Finance News – Blueprint Medicines
What is your interest today?
Bitcoin
Crypto
Btc
Tariffs
Ceo
Cryptocurrency
Crypto Assets
Stocks
Investors
Stock
Shares
Stock Market
Ethereum
Markets
Price
Xrp
Investment
Blockchain
Sec
Stablecoin
Eth
Etf
Trade
Earnings
Revenue
Solana
Index
China
Bse
Coinbase
Ipo
Token
Wall Street
Nasdaq
Trade War
Usd
Interest Rates
Inflation
Economy
Profit
Digital Assets
Sensex
Sp 500
Gold
Nvidia
Nse
Binance
Federal Reserve
Tesla
Treasury
Stock Markets
Usdb
Spx6900
Price Pressure
Aal
Tax Savings
Smarter Web Company
Sui Foundation
Equity Instruments
Tariff Impacts
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Investopedia • Jun 02, 2025
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover
The agreement for a multibillion-dollar acquisition by Sanofi has led to a notable increase in the market value of Blueprint Medicines shares.
Read Full Article →